ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00285428
Recruitment Status : Completed
First Posted : February 2, 2006
Last Update Posted : February 6, 2012
Sponsor:
Information provided by:
Immunomedics, Inc.